Cellistic
  • Platforms
    • Pulse
    • Echo
    • Echo - NK
  • Allo Chassis™
  • Our Approach
    • Donor-Derived Allogeneic
    • iPSC-Based Allogeneic
    • Autologous
  • News & Events
    • Insights
    • Events
  • About
    • Team
    • Facility
    • Careers
  • Contact

Expert Opinion

All Announcements Events Expert Opinion Interviews Podcasts Posters Webinars
Enhancing precision in iPSC Allogeneic Cell Therapy through advanced gene-editing strategies

May 14, 2024

Enhancing precision in iPSC Allogeneic Cell Therapy through advanced ...

Induced pluripotent stem cells (iPSCs) have recently emerged as a promising avenue for ...

Converting iPSC to T Cells: Key Challenges and Considerations

March 12, 2024

Converting iPSC to T Cells: Key Challenges and Considerations

Chimeric antigen receptor (CAR)-engineered T cells (CAR-T) have been remarkably successful in ...

Shifting Tides: Unleashing the Potential of iPSC-Based Allogeneic Cell Therapy

August 29, 2023

Shifting Tides: Unleashing the Potential of iPSC-Based Allogeneic Cell ...

As the limitations of autologous cell therapy approaches become evident, many cell therapy ...

The benefits of allogeneic cell therapy

November 10, 2022

The benefits of allogeneic cell therapy

Cell therapies hold great promise as new medical interventions. Diseases that until recently ...

← 1 2 3
Cellistic

Rue Edouard Belin 2
1435 Mont-Saint-Guibert
Belgium BE-Belgium-Flag

partnering@cellistic.com

  • Platforms
  • Allo Chassis™
  • Our Approach
  • News & Events
  • About
  • Contact
  • Privacy Policy
  • Cookie Policy
  • Team
  • Careers
X twitter x-twitter Linkedin